Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet
Some health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read MoreSome health plans and employers are still reluctant to cover Wegovy due to its hefty price tag, which they say
Read MoreThe FDA's decision means Madrigal has succeeded in a disease area that several larger companies have failed — or are
Read MoreAmazon Pharmacy second online pharmacy to partner with Eli Lilly's site, and could provide faster deliveries for certain patients. Source
Read MoreThe pharmaceutical giant has been trying to shore up investor sentiment after its shares fell more than 40% in 2023.
Read MoreLars Fruergaard Jørgensen's remarks came one day after Novo Nordisk impressed investors with early-stage trial data on amycretin. Source link
Read MoreThe FDA plans to call a last-minute meeting of its outside advisors to further review the Eli Lilly Alzheimer's treatment's
Read MoreSome Wall Street analysts said Viking's experimental obesity treatment may be "best-in-class" following the release of midstage trial data. Source
Read MoreCVS and Walgreens have received certification from the FDA to dispense the commonly used mifepristone at their retail pharmacies, spokespeople
Read MoreThe total amount Novavax will pay depends on whether Gavi decides to order more Covid shots from the cash-strapped company
Read More